Khan Seema A, Wolfman Judy A, Segal Lewis, Benjamin Stephanie, Nayar Ritu, Wiley Elizabeth L, Bryk Michele, Morrow Monica
Lynn Sage Comprehensive Breast Center, Feinberg School of Medicine of Northwestern University, 675 North St. Clair Street, Galter 13-174, Chicago, Illinois , 60614, USA.
Ann Surg Oncol. 2005 Sep;12(9):689-96. doi: 10.1245/ASO.2005.04.037. Epub 2005 Jul 27.
We designed a prospective study to assess the likelihood that early lesions presenting as mammographic calcifications could be accessed for cytological diagnosis by ductal lavage (DL).
Consenting women with calcifications (Breast Imaging Reporting and Data System 4 or 5) underwent DL of fluid-yielding ducts (FYDs) before stereotactic core or excisional biopsy. The DL catheter was used to inject .2 to 1 mL of Isovue 300 into the duct to determine whether the FYD corresponded to the duct containing calcifications (designated overlap). Additional FYDs were injected, if possible, until overlap was identified. DL cytology was compared with histology.
Twenty women were enrolled (mean age, 54.2 years); the mean size of the calcification-bearing area was 190 mm(2). The histological findings were as follows: 1 invasive cancer, 9 ductal carcinomas-in-situ (DCIS), 5 atypical hyperplasias, and 5 usual hyperplasias or fibrocystic changes. Four women had no FYD. In 15 women who underwent DL and ductography, overlap of dye and calcifications was seen in 4 (27%): 1 fibrocystic change, 1 hyperplasia, 1 atypical hyperplasia (cytological diagnosis mildly atypical), and 1 DCIS (cytological diagnosis benign). Of the remaining 8 DCIS lesions, 4 had no nipple aspiration fluid, 1 showed extravasation, and 3 were lavaged but the duct did not overlap.
These results are consistent with data from women undergoing mastectomy for larger invasive cancer and DCIS and show that cancer-containing ducts do not yield nipple fluid in most cases.
我们设计了一项前瞻性研究,以评估通过导管灌洗(DL)获取表现为乳腺钼靶钙化的早期病变进行细胞学诊断的可能性。
同意参与研究的有钙化(乳腺影像报告和数据系统4级或5级)的女性,在立体定向核心活检或切除活检前,对产生液体的导管(FYD)进行DL。使用DL导管向导管内注入0.2至1毫升碘克沙醇300,以确定FYD是否与含有钙化的导管相对应(称为重叠)。如有可能,对额外的FYD进行注射,直到确定重叠。将DL细胞学与组织学进行比较。
招募了20名女性(平均年龄54.2岁);含钙化区域的平均大小为190平方毫米。组织学结果如下:1例浸润性癌,9例导管原位癌(DCIS),5例非典型增生,5例普通增生或纤维囊性改变。4名女性没有FYD。在15名接受DL和导管造影的女性中,4名(27%)可见染料与钙化重叠:1例纤维囊性改变,1例增生,1例非典型增生(细胞学诊断为轻度非典型),1例DCIS(细胞学诊断为良性)。在其余8例DCIS病变中,4例没有乳头抽吸液,1例出现外渗,3例进行了灌洗但导管没有重叠。
这些结果与因较大浸润性癌和DCIS接受乳房切除术的女性的数据一致,表明大多数情况下,含有癌症的导管不会产生乳头液。